NasdaqGS:ICLRLife Sciences
ICON (ICLR) Is Down 38.2% After Internal Revenue Probe And Pulled 2025 Outlook - What's Changed
ICON plc previously disclosed that its Audit Committee launched an internal investigation into revenue recognition practices from 2023 to 2025, prompting delays to its fourth-quarter and full-year 2025 results and the withdrawal of 2025 financial guidance while it prepares to report material weaknesses in internal controls.
Preliminary findings indicating revenue overstatements of less than 2% per year, combined with multiple securities law probes, have raised wider questions about ICON’s...